BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38727812)

  • 1. Single-cell sequencing of tumour infiltrating T cells efficiently identifies tumour-specific T cell receptors based on the T cell activation score.
    Zhang C; Li S; Shen L; Teng X; Xiao Y; Yang W; Lu Z
    Cancer Immunol Immunother; 2024 May; 73(7):123. PubMed ID: 38727812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of T cell receptor specifically reactive with autologous tumour cells from tumour-infiltrating lymphocytes and construction of T cell receptor engineered T cells for esophageal squamous cell carcinoma.
    Tan Q; Zhang C; Yang W; Liu Y; Heyilimu P; Feng D; Xing L; Ke Y; Lu Z
    J Immunother Cancer; 2019 Aug; 7(1):232. PubMed ID: 31462302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Tumoricidal TCRs from Tumor-Infiltrating Lymphocytes by Single-Cell Analysis.
    Shitaoka K; Hamana H; Kishi H; Hayakawa Y; Kobayashi E; Sukegawa K; Piao X; Lyu F; Nagata T; Sugiyama D; Nishikawa H; Tanemura A; Katayama I; Murahashi M; Takamatsu Y; Tani K; Ozawa T; Muraguchi A
    Cancer Immunol Res; 2018 Apr; 6(4):378-388. PubMed ID: 29475880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 Expression.
    Parkhurst M; Gros A; Pasetto A; Prickett T; Crystal JS; Robbins P; Rosenberg SA
    Clin Cancer Res; 2017 May; 23(10):2491-2505. PubMed ID: 27827318
    [No Abstract]   [Full Text] [Related]  

  • 5. An Efficient Single-Cell RNA-Seq Approach to Identify Neoantigen-Specific T Cell Receptors.
    Lu YC; Zheng Z; Robbins PF; Tran E; Prickett TD; Gartner JJ; Li YF; Ray S; Franco Z; Bliskovsky V; Fitzgerald PC; Rosenberg SA
    Mol Ther; 2018 Feb; 26(2):379-389. PubMed ID: 29174843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expansion of Tumor-reactive T Cells From Patients With Pancreatic Cancer.
    Meng Q; Liu Z; Rangelova E; Poiret T; Ambati A; Rane L; Xie S; Verbeke C; Dodoo E; Del Chiaro M; Löhr M; Segersvärd R; Maeurer MJ
    J Immunother; 2016; 39(2):81-9. PubMed ID: 26849077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen/HLA-agnostic strategies for Characterizing Tumor-responsive T cell receptors in PDAC patients via single-cell sequencing and autologous organoid application.
    Wang X; Dai Z; Lin X; Zou X; Wang R; Tasiheng Y; Yan Y; Ma M; Chen Y; Cheng H; Liu C; Yu X
    Cancer Lett; 2024 Apr; 588():216741. PubMed ID: 38395378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing.
    Guo X; Zhang Y; Zheng L; Zheng C; Song J; Zhang Q; Kang B; Liu Z; Jin L; Xing R; Gao R; Zhang L; Dong M; Hu X; Ren X; Kirchhoff D; Roider HG; Yan T; Zhang Z
    Nat Med; 2018 Jul; 24(7):978-985. PubMed ID: 29942094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-cell RNA sequencing reveals heterogeneous tumor and immune cell populations in early-stage lung adenocarcinomas harboring EGFR mutations.
    He D; Wang D; Lu P; Yang N; Xue Z; Zhu X; Zhang P; Fan G
    Oncogene; 2021 Jan; 40(2):355-368. PubMed ID: 33144684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TCR function analysis using a novel system reveals the multiple unconventional tumor-reactive T cells in human breast cancer-infiltrating lymphocytes.
    Yamaguchi S; Hamana H; Shitaoka K; Sukegawa K; Nagata T; Hayee A; Kobayashi E; Ozawa T; Fujii T; Muraguchi A; Tobe K; Kishi H
    Eur J Immunol; 2021 Sep; 51(9):2306-2316. PubMed ID: 34171120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid identification of tumor-reactive T-cell receptors by RNA preamplification-based single-cell sequencing.
    Ma Y; Liu F; Li B; Zhou H; Qiao D; Deng L; Wu H; Fang F; Wang Y; Yao D; Hu G; Qian Y; Wang M
    J Immunol Methods; 2022 May; 504():113260. PubMed ID: 35331733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phenotypic signature that identifies neoantigen-reactive T cells in fresh human lung cancers.
    Hanada KI; Zhao C; Gil-Hoyos R; Gartner JJ; Chow-Parmer C; Lowery FJ; Krishna S; Prickett TD; Kivitz S; Parkhurst MR; Wong N; Rae Z; Kelly MC; Goff SL; Robbins PF; Rosenberg SA; Yang JC
    Cancer Cell; 2022 May; 40(5):479-493.e6. PubMed ID: 35452604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of T-cell receptor and B-cell receptor repertoire on the recurrence of early stage lung adenocarcinoma.
    Liu J; Yang X; Lu X; Zhang L; Luo W; Cheng Y; Zhang L; Yang Y; Dai N; Xu Y; Guan Y; Xiao H; Li M; Wang D
    Exp Cell Res; 2020 Sep; 394(2):112134. PubMed ID: 32540399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in TCR repertoire and T cell activation underlie the divergent outcomes of antitumor immune responses in tumor-eradicating versus tumor-progressing hosts.
    Woolaver RA; Wang X; Krinsky AL; Waschke BC; Chen SMY; Popolizio V; Nicklawsky AG; Gao D; Chen Z; Jimeno A; Wang XJ; Wang JH
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33414263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell surface marker-based capture of neoantigen-reactive CD8
    Chatani PD; Lowery FJ; Parikh NB; Hitscherich KJ; Yossef R; Hill V; Gartner JJ; Paria B; Florentin M; Ray S; Bera A; Parkhust M; Robbins P; Krishna S; Rosenberg SA
    J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37258038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced detection of neoantigen-reactive T cells targeting unique and shared oncogenes for personalized cancer immunotherapy.
    Yossef R; Tran E; Deniger DC; Gros A; Pasetto A; Parkhurst MR; Gartner JJ; Prickett TD; Cafri G; Robbins PF; Rosenberg SA
    JCI Insight; 2018 Oct; 3(19):. PubMed ID: 30282837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct identification of neoantigen-specific TCRs from tumor specimens by high-throughput single-cell sequencing.
    Lu YC; Zheng Z; Lowery FJ; Gartner JJ; Prickett TD; Robbins PF; Rosenberg SA
    J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34321276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of PD-L1, PD-L2, and IDO1 on tumor cells and density of CD8-positive tumor-infiltrating lymphocytes in early-stage lung adenocarcinoma according to histological subtype.
    Takada K; Toyokawa G; Kinoshita F; Jogo T; Kohashi K; Wakasu S; Ono Y; Tanaka K; Oba T; Osoegawa A; Tagawa T; Azuma K; Okamoto I; Shimokawa M; Oda Y; Mori M
    J Cancer Res Clin Oncol; 2020 Oct; 146(10):2639-2650. PubMed ID: 32405745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-cell RNA sequencing reveals distinct tumor microenvironmental patterns in lung adenocarcinoma.
    Bischoff P; Trinks A; Obermayer B; Pett JP; Wiederspahn J; Uhlitz F; Liang X; Lehmann A; Jurmeister P; Elsner A; Dziodzio T; Rückert JC; Neudecker J; Falk C; Beule D; Sers C; Morkel M; Horst D; Blüthgen N; Klauschen F
    Oncogene; 2021 Dec; 40(50):6748-6758. PubMed ID: 34663877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional HPV-specific PD-1
    Eberhardt CS; Kissick HT; Patel MR; Cardenas MA; Prokhnevska N; Obeng RC; Nasti TH; Griffith CC; Im SJ; Wang X; Shin DM; Carrington M; Chen ZG; Sidney J; Sette A; Saba NF; Wieland A; Ahmed R
    Nature; 2021 Sep; 597(7875):279-284. PubMed ID: 34471285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.